Guidelines Liaison; cHFSA Representative; dASE Representative; eHRS Representative;
fSCMR Representative; gAATS Representative; hSCAI Representative; and iFormer Joint …

Abstract Purpose of Review We provide a state of the art of therapeutic options in
hypertrophic cardiomyopathy (HCM), focusing on recent advances in our understanding of …

Mutations in atrial-enriched genes can cause a primary atrial myopathy that can contribute to
overall cardiovascular dysfunction. MYBPHL encodes myosin-binding protein H-like (MyBP …

Hypertrophic cardiomyopathy (HCM) is a genetic disorder caused by pathogenic variants in
sarcomeric genes, leading to left ventricular hypertrophy and complex phenotypic …

Hypertrophic cardiomyopathy (HCM) is a common inherited monogenic disease with a
prevalence of 1/500 in the general population, representing an important cause of …

Hypertrophic cardiomyopathy (HCM) is widely recognized as one of the most common
inheritable cardiac disorders. Since its initial description over 60 years ago, advances in …

Objective To investigate the prognostic significance of T1 mapping using T1 long and short
in hypertrophic cardiomyopathy (HCM) patients. Methods A total of 263 consecutive patients …

Background: Hypertrophic cardiomyopathy (HCM) is characterized by asymmetric left
ventricular hypertrophy. Currently, hypertrophy pathways responsible for HCM have not …

Genetic cardiomyopathies have been studied for decades, and it has become increasingly
clear that these progressive diseases are more complex than originally thought. These …

Heritable cardiomyopathies are a class of heart diseases caused by variations in a number
of genetic loci. Genetic variants on one allele lead to either a degraded protein, which …